Diabetes — all decisions

The appeal seeking revision on the basis of clear and unmistakable error (CUE) of the October 2015 rating decision that assigned an effective date of June 24, 2015, for the award of service connection for diabetes mellitus type II was denied. The October 2015 rating decision was revised to reflect an earlier effective date of June 24, 2014, for the award of service connection for coronary artery disease (CAD).

The Board granted service connection for diabetic retinopathy, peripheral neuropathy of the upper extremities, kidney condition, obstructive sleep apnea, asthma, and tinnitus.

The Board granted service connection for gangrenous gallbladder and hemorrhagic necrotizing pancreatitis, to include as due to Agent Orange exposure. Service connection was also granted for diabetes mellitus type I as secondary to the Veteran's service-connected hemorrhagic necrotizing pancreatitis. The Board denied a compensable rating for hypertension and noncompensable ratings for melanoma and squamous cell cancer removal scars (trunk) and facial scars.

The Board remands the claims for service connection for left knee strain, right knee strain, and diabetes due to a need for additional medical opinions.

The Board denied service connection for anxiety and a higher rating for PTSD, but remanded claims for diabetes mellitus, skin markings from toxic exposure, left knee disorder, right knee disorder, and lumbar spine disorder.

The Board remands the claim for a higher disability rating for diabetes mellitus type 2 due to the Veteran's failure to attend a scheduled VA examination without good cause, which was determined to be a pre-decisional duty-to-assist error.

The Board denied service connection for diabetes mellitus and remanded the claim for a left ankle Achilles tendon rupture status post-surgery with ankle sprain.

The Board granted service connection for diabetes mellitus, type II based on the Veteran's presumed exposure to herbicide agents in Thailand under the PACT Act.

The Board granted service connection for diabetes mellitus, type II as secondary to a bilateral knee disability and an effective date of October 14, 2020 for the award of service connection for migraine headaches.

The Board granted service connection for diabetes mellitus, a bilateral foot disability (other than bilateral plantar fasciitis), to include gout, right hand and left hand disabilities, as well as a thyroid disorder, all secondary to the Veteran's service-connected obstructive sleep apnea. The Board also granted a TDIU from September 25, 2020.

The Board denied the veteran's claims for increased ratings and service connection, as well as a TDIU.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on the need for aid and attendance or housebound status due to his service-connected disabilities not meeting the criteria.

The Board denied the Veteran's claim for service connection for diabetes mellitus type II, finding that there was no evidence of exposure to herbicide agents and that the condition did not have its onset in or is otherwise related to his active duty service.

The Board of Veterans' Appeals (Board) remands the claims for service connection for various conditions, including an acquired psychiatric disorder, aortic tear, cataracts, diabetes mellitus, GERD, and hearing loss.

The Board denied service connection for bilateral tinnitus and bilateral hearing loss due to the lack of a current diagnosis, and remanded claims for diabetes mellitus type II and hypertension associated with herbicide exposure for further development.

The Board denied service connection for hypertension and remanded the claim for diabetes mellitus, type II under 38 U.S.C. § 1151.

The Board granted a rating of 50 percent for major depressive disorder with alcohol use disorder and cognitive impairment from May 1, 2017 to December 10, 2019; denied a rating in excess of 70 percent from December 11, 2019 to February 6, 2023. The Board granted ratings of 20 percent for right and left lower extremity sciatic nerve peripheral neuropathy from May 1, 2017 to February 6, 2023; denied a rating in excess of 20 percent on and after February 7, 2023. The Board granted an initial 10 percent rating for hypertension effective August 10, 2022.

The appeal is remanded to correct a pre-decisional duty to assist error by the AOJ.

The Board granted service connection for diabetes mellitus type II, finding that the Veteran's service-connected depressive disorder caused his obesity, which in turn led to the development of diabetes.

The Board granted service connection for coronary artery disease, diabetes mellitus type II, and left and right lower extremity diabetic neuropathy due to exposure to contaminated drinking water at Camp Lejeune during service. Service connection for obstructive sleep apnea was remanded.